Elixia COVID-19 is a clinical research site located in Hollywood, Florida, United States 33024.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Elixia COVID-19 has participated in 1 clinical trials.
Therapeutic areas: Immunocompromised.
Sponsors: Regeneron Pharmaceuticals.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Elixia COVID-19 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Elixia COVID-19 has 1 clinical trials on record. Their work covers Immunocompromised.
Elixia COVID-19 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.